![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Blue light improves cognitive performance
A newly discovered system of photoreceptors for circadian rhythms works non-visual and responds to blue light (460 nm). We report a longitudinal study in 44 adults, showing that a significant increase in alert...
-
Article
Open AccessInduction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
A recent phase I study showed that weekly cisplatin, irinotecan and concurrent radiotherapy can be administered with moderate toxicity in patients with oesophageal cancer. Patients with no prior treatment and ...
-
Article
Open Access‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’
This phase II trial was performed to evaluate the efficacy and tolerability of a new combination of Uracil/Ftorafur (UFT®)/leucovorin (LV) and oxaliplatin in patients (pts) with metastatic colorectal cancer (MCRC...
-
Article
Open AccessCarcinoma of the oesophagus
-
Chapter and Conference Paper
Conservative treatment of esophagus cancer concomitant chemoradiotherapy treatment. First results of a 143 patients serial
Since the first publication in 1981 from the Wayne State University by Steiger and Franklin [1], the concomitant radio-chemotherapy has been used by many teams in the world for the treatment of œsophageal cancer.
-
Chapter and Conference Paper
Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
Radiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson [1], The 1-year survival rate var...
-
Chapter and Conference Paper
Dominant Formation and Quenching Processes in E-Beam Pumped ArF* and KrF* Lasers
The dominant formation and quenching processes in E-beam pumped ArF* and KrF* lasers are discussed. The exciplexes are produced by irradiating Ar/F2 and Ar/Kr/F2 mixtures with a 5A/cm2, 150 keV E-beam. A steady s...